Stealth BioTherapeutics (Stealth BioTherapeutics) Long-Term Debt : $13.78 Mil (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Long-Term Debt?

Stealth BioTherapeutics's Long-Term Debt for the quarter that ended in Mar. 2022 was $13.78 Mil.

Stealth BioTherapeutics's quarterly Long-Term Debt increased from Sep. 2021 ($13.54 Mil) to Dec. 2021 ($13.66 Mil) and increased from Dec. 2021 ($13.66 Mil) to Mar. 2022 ($13.78 Mil).

Stealth BioTherapeutics's annual Long-Term Debt declined from Dec. 2019 ($1.53 Mil) to Dec. 2020 ($0.00 Mil) but then increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($13.66 Mil).

Stealth BioTherapeutics Long-Term Debt Historical Data

The historical data trend for Stealth BioTherapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Long-Term Debt Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Long-Term Debt

Get a 7-Day Free Trial

61.96

113.57

1.53

13.66

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Long-Term Debt	Get a 7-Day Free Trial															-	-	13.54	13.66	13.78

Stealth BioTherapeutics (NAS:MITO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Stealth BioTherapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.